Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms

Background: Giant vertebrobasilar aneurysms (GVBAs) have an unfavorable natural history if left untreated and often pose a sizeable challenge to endovascular treatment. The aim of this study was to analyze the angiographic and clinical outcomes of GVBAs treated by various endovascular procedures.Met...

Full description

Bibliographic Details
Main Authors: Miao Li, Huaxin Liang, Jie Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.00748/full
_version_ 1818495533646348288
author Miao Li
Huaxin Liang
Jie Wang
author_facet Miao Li
Huaxin Liang
Jie Wang
author_sort Miao Li
collection DOAJ
description Background: Giant vertebrobasilar aneurysms (GVBAs) have an unfavorable natural history if left untreated and often pose a sizeable challenge to endovascular treatment. The aim of this study was to analyze the angiographic and clinical outcomes of GVBAs treated by various endovascular procedures.Methods: Between January 2010 and September 2018, 27 patients with 27 GVBAs treated endovascularly were enrolled in this consecutive study. The clinical and angiographic features, treatment modalities, and outcomes were analyzed.Results: The patient cohort comprised 21 men (77.8%) and 6 women (22.2%) of mean age 42.7 ± 18.9 years (range, 6–65 years). The most common presenting symptom was compressive symptoms, present in 15 patients (55.6%). None of the GVBAs was ruptured. Of the 27 GVBAs, 23 aneurysms were dissecting aneurysm with intramural hematoma and 4 aneurysms were saccular. Regarding treatment approach, internal trapping was used in 5 aneurysms, stent-assisted coil embolization in 10, sole stenting in 4, and flow diverters in 8. Overall, 12 patients (44.4%) had an unfavorable angiographic or clinical outcome: 3 patients presented with post-operative complications and subsequent death, and 9 with poor prognosis during follow-up.Conclusions: Patients with GVBAs may not benefit from endovascular treatment. Newer-generation devices are necessary to provide more optimal therapy for the management of these complex lesions.
first_indexed 2024-12-10T18:21:46Z
format Article
id doaj.art-b41853ba92454975955e82d369e49b97
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-10T18:21:46Z
publishDate 2020-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-b41853ba92454975955e82d369e49b972022-12-22T01:38:11ZengFrontiers Media S.A.Frontiers in Neurology1664-22952020-08-011110.3389/fneur.2020.00748484761Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar AneurysmsMiao Li0Huaxin Liang1Jie Wang2Department of Neurosurgery, The China-Japan Union Hospital of Jilin University, Changchun, ChinaDepartment of Neurosurgery, The China-Japan Union Hospital of Jilin University, Changchun, ChinaDepartment of Neurology, The China-Japan Union Hospital of Jilin University, Changchun, ChinaBackground: Giant vertebrobasilar aneurysms (GVBAs) have an unfavorable natural history if left untreated and often pose a sizeable challenge to endovascular treatment. The aim of this study was to analyze the angiographic and clinical outcomes of GVBAs treated by various endovascular procedures.Methods: Between January 2010 and September 2018, 27 patients with 27 GVBAs treated endovascularly were enrolled in this consecutive study. The clinical and angiographic features, treatment modalities, and outcomes were analyzed.Results: The patient cohort comprised 21 men (77.8%) and 6 women (22.2%) of mean age 42.7 ± 18.9 years (range, 6–65 years). The most common presenting symptom was compressive symptoms, present in 15 patients (55.6%). None of the GVBAs was ruptured. Of the 27 GVBAs, 23 aneurysms were dissecting aneurysm with intramural hematoma and 4 aneurysms were saccular. Regarding treatment approach, internal trapping was used in 5 aneurysms, stent-assisted coil embolization in 10, sole stenting in 4, and flow diverters in 8. Overall, 12 patients (44.4%) had an unfavorable angiographic or clinical outcome: 3 patients presented with post-operative complications and subsequent death, and 9 with poor prognosis during follow-up.Conclusions: Patients with GVBAs may not benefit from endovascular treatment. Newer-generation devices are necessary to provide more optimal therapy for the management of these complex lesions.https://www.frontiersin.org/article/10.3389/fneur.2020.00748/fullgiant vertebrobasilar aneurysmsendovascular treatmentoutcomecomplicationspoor prognosis
spellingShingle Miao Li
Huaxin Liang
Jie Wang
Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms
Frontiers in Neurology
giant vertebrobasilar aneurysms
endovascular treatment
outcome
complications
poor prognosis
title Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms
title_full Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms
title_fullStr Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms
title_full_unstemmed Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms
title_short Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms
title_sort unfavorable outcomes related to endovascular treatment of giant vertebrobasilar aneurysms
topic giant vertebrobasilar aneurysms
endovascular treatment
outcome
complications
poor prognosis
url https://www.frontiersin.org/article/10.3389/fneur.2020.00748/full
work_keys_str_mv AT miaoli unfavorableoutcomesrelatedtoendovasculartreatmentofgiantvertebrobasilaraneurysms
AT huaxinliang unfavorableoutcomesrelatedtoendovasculartreatmentofgiantvertebrobasilaraneurysms
AT jiewang unfavorableoutcomesrelatedtoendovasculartreatmentofgiantvertebrobasilaraneurysms